William Huggins, PA
Medical · Dallas, TXNPI 1316196157
Payments from drug & device makers
Across 402 payments — averaging $22.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$3K
- Insmed, Inc.$799
- Merck$596
- Shionogi Inc$584
- Gilead$490
- EMD Serono, Inc.$471
- plus $3K from 16 others
Across 3 payments — averaging $249.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Viiv Healthcare Company$749
What the payments were for
- Speaking & faculty fees$360%
- Food & beverage$8,75297%
- Education$2032%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 124 | $3,360 |
| Insmed, Inc. | 30 | $799 |
| Merck | 25 | $596 |
| Shionogi Inc | 35 | $584 |
| Gilead | 20 | $490 |
| EMD Serono, Inc. | 31 | $471 |
| AbbVie | 22 | $452 |
| Astellas Pharma US Inc | 16 | $371 |
| Paratek Pharmaceuticals, Inc. | 22 | $339 |
| Theratechnologies Inc. | 14 | $244 |
| Johnson & Johnson | 13 | $237 |
| Napo Pharmaceuticals Inc | 10 | $216 |
| Ferring Pharmaceuticals Inc. | 8 | $207 |
| Aimmune Therapeutics, Inc. | 11 | $181 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $134 |
| Octapharma USA, Inc. | 3 | $78 |
| La Jolla Pharmaceutical Company | 3 | $69 |
| Melinta Therapeutics, LLC | 4 | $58 |
| Mayne Pharma Commercial LLC | 2 | $44 |
| Pfizer | 1 | $23 |
| Amarin Pharma, Inc. | 1 | $23 |
| Cumberland Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,991 in reported general payments places this provider in the 90th percentile of 1,490 medical providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Minocycline Hcl | 43 | $997 |
| Doxycycline Hyclate | 11 | $400 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $368 |
| Fluconazole | 15 | $177 |
Paid to pharmacies, not to this prescriber.
Other medical in Dallas
- Kimberly PoarchDallas$166K
- Erin DuhaimeDallas$150K
- Danny DeckardDallas$101K
- Janine ShinnDallas$84K
- Andrew GarzaDallas$43K
- Alyssa SpiegelDallas$18K
- Jose de la CerdaSan Antonio$1.1M
- Mark DavisFort Worth$1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.